Flt-1 has also been investigated for its role in cancer where it acts as a positive regulator of the pathological angiogenesis seen with tumor formation[89], which opposes the physiological role of Flt-1 as a negative angiogenic regulator. This evidence concerns the gene FLT1 and cancer.